Companies / United Kingdom
Shire Divests Product Basket
October 2007 | Industry NewsUK drugmaker Shire Pharmaceuticals has announced that it is planning to sell a basket of medicines to Spanish drugmaker Almirall for US$213mn, as it looks to focus on core-products in key therapeutic areas such as Attention Deficit Hyperactivity Disorder (ADHD).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
